News

A gene expression profile-based test can spot melanoma patients who have a low risk of cancer spreading to their lymph nodes.

Research reveals that the combination of palbociclib and telaglenastat, two drugs with complementary actions, could help improve the clinical treatment of this type of cancer, the third most common worldwide.

New research has shown that triple-negative breast cancer is fuelled by lipids and fatty acids that are a key feature of obesity.

A new antibody therapy strategy that restricts the growth of breast cancer cells could provide a treatment option for the most aggressive forms of breast cancer.

A small non-randomized retrospective study of a drug called pazopanib has shown that it increases children’s survival without major side-effects.

A blood-based liquid biopsy model, called the Liquid Biomaker of Immunotherapy Outcomes score, allows researchers to predict how likely patients are to respond to immune checkpoint blockade drugs.

Discover the potential of infrared spectroscopy for enhancing cancer treatments through precise drug tracking using modified doxorubicin.

Attaching "fake targets" to tumor cells to guide immune cell attacks could overcome the limitations of conventional antibody-based therapies.

UCLA researchers have developed a CAR-NKT cell therapy that has been shown to be more effective than current immunotherapies at fighting cancer in tumor samples from late-stage triple-negative breast cancer patients.

A new cancer treatment combines LED light and tiny tin flakes to neutralize cancer cells while shielding healthy cells.